Waikakul Saranatra, Aresanasuwan Thanyawan, Makadilog Sahachat, Playlex Jirapa, Maungtham Rathathai, Vajaradul Youngyudh
J Med Assoc Thai. 2016 Nov;99(11):1173-9.
Bangkok Biomaterial Center is the only allogenic bone bank in Thailand, supplying the bones to all medical centers. From a report, a certain number of post-operative complications were found.
To compare pre-protocol revision and post-protocol revision success rates and complications associated with the use of allogenic bone grafts relative to perioperative handling and care of allogenic bone.
This retrospective comparative study was conducted at the Bangkok Biomaterial Center, Faculty of Medicine Siriraj Hospital, Mahidol University. All registration forms and surgical follow-up reports relating to the use allogenic bones procured from our bone bank between 2005 and 2015 were reviewed. New recommendations for the use of our allogenic bones were established in 2009. Results and complications after allogenic bone transplantation between 2005 and 2008 were compared with results and complications after transplantation to a new protocol between 2009 and 2015. Descriptive analysis and analysis of variance were used to evaluate the data.
Data of 825 patients who underwent deep frozen allogenic bone transplantation and 1,541 patients who underwent freeze-dried allogenic bone transplantation were retrospectively reviewed. Overall, the complication rate was reduced from 14.83% in the pre-protocol revision period to 5.15% in the period after the new recommendations for perioperative graft handling were established and implemented.
New recommendations for the handling and care of allogenic bone during the perioperative period significantly reduced post-operative complications in patients who received transplantation with deep frozen allogenic bone. The infection rate in patients who received allogenic bone graft was very low.
曼谷生物材料中心是泰国唯一的同种异体骨库,为所有医疗中心供应骨骼。从一份报告中发现了一定数量的术后并发症。
比较术前方案修订前后的成功率以及与同种异体骨移植使用相关的并发症,这些并发症与同种异体骨的围手术期处理和护理有关。
这项回顾性比较研究在玛希隆大学诗里拉吉医院医学院的曼谷生物材料中心进行。回顾了2005年至2015年期间从我们骨库获取的同种异体骨使用的所有登记表和手术随访报告。2009年制定了使用我们同种异体骨的新建议。比较了2005年至2008年同种异体骨移植后的结果和并发症与2009年至2015年采用新方案移植后的结果和并发症。采用描述性分析和方差分析来评估数据。
回顾性分析了825例接受深冻同种异体骨移植患者和1541例接受冻干同种异体骨移植患者的数据。总体而言,并发症发生率从术前方案修订期的14.83%降至围手术期移植物处理新建议制定并实施后的5.15%。
围手术期同种异体骨处理和护理的新建议显著降低了接受深冻同种异体骨移植患者的术后并发症。接受同种异体骨移植患者的感染率非常低。